Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 29% ± 11% | |
CD16-negative, CD56-bright natural killer cell, human | 4 studies | 16% ± 0% | |
classical monocyte | 4 studies | 20% ± 3% | |
ciliated cell | 4 studies | 25% ± 5% | |
non-classical monocyte | 3 studies | 23% ± 5% | |
dendritic cell | 3 studies | 29% ± 7% | |
plasmacytoid dendritic cell | 3 studies | 23% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 21% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 2081.05 | 258 / 258 | 100% | 12.30 | 230 / 230 |
esophagus | 100% | 1514.73 | 1445 / 1445 | 100% | 11.56 | 183 / 183 |
lung | 100% | 2006.87 | 578 / 578 | 100% | 13.08 | 1155 / 1155 |
ovary | 100% | 1490.28 | 180 / 180 | 100% | 15.16 | 430 / 430 |
thymus | 100% | 2898.91 | 653 / 653 | 100% | 16.83 | 605 / 605 |
uterus | 100% | 1643.78 | 170 / 170 | 100% | 16.69 | 459 / 459 |
prostate | 100% | 2903.56 | 245 / 245 | 100% | 14.22 | 501 / 502 |
skin | 100% | 1751.54 | 1809 / 1809 | 100% | 10.63 | 471 / 472 |
brain | 100% | 1718.90 | 2634 / 2642 | 100% | 10.79 | 705 / 705 |
stomach | 100% | 1591.72 | 359 / 359 | 100% | 11.14 | 285 / 286 |
intestine | 100% | 1981.22 | 966 / 966 | 100% | 11.55 | 525 / 527 |
bladder | 100% | 1605.62 | 21 / 21 | 100% | 14.57 | 502 / 504 |
breast | 100% | 1619.17 | 459 / 459 | 100% | 16.22 | 1113 / 1118 |
liver | 100% | 1990.24 | 226 / 226 | 100% | 9.23 | 404 / 406 |
kidney | 100% | 2270.67 | 89 / 89 | 99% | 10.42 | 895 / 901 |
pancreas | 100% | 935.56 | 327 / 328 | 99% | 12.46 | 176 / 178 |
adipose | 100% | 1323.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 10.29 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.51 | 29 / 29 |
spleen | 100% | 2733.51 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.37 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.93 | 1 / 1 |
blood vessel | 100% | 1217.63 | 1330 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 1896.59 | 917 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 958.42 | 840 / 861 | 0% | 0 | 0 / 0 |
muscle | 97% | 769.14 | 778 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005980 | Biological process | glycogen catabolic process |
GO_0006091 | Biological process | generation of precursor metabolites and energy |
GO_0006468 | Biological process | protein phosphorylation |
GO_0005978 | Biological process | glycogen biosynthetic process |
GO_0045819 | Biological process | positive regulation of glycogen catabolic process |
GO_0005977 | Biological process | glycogen metabolic process |
GO_0005964 | Cellular component | phosphorylase kinase complex |
GO_0005829 | Cellular component | cytosol |
GO_0019899 | Molecular function | enzyme binding |
GO_0005516 | Molecular function | calmodulin binding |
GO_0050321 | Molecular function | tau-protein kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004689 | Molecular function | phosphorylase kinase activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | PHKG2 |
Protein name | non-specific serine/threonine protein kinase (EC 2.7.11.1) Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2) phosphorylase kinase (EC 2.7.11.19) Phosphorylase kinase catalytic subunit gamma 2 |
Synonyms | |
Description | FUNCTION: Catalytic subunit of the phosphorylase b kinase (PHK), which mediates the neural and hormonal regulation of glycogen breakdown (glycogenolysis) by phosphorylating and thereby activating glycogen phosphorylase. May regulate glycogeneolysis in the testis. In vitro, phosphorylates PYGM (By similarity). . |
Accessions | ENST00000424889.7 [P15735-2] ENST00000561712.1 P15735 H3BTW6 ENST00000328273.11 ENST00000563607.1 J3KNN3 H3BP07 ENST00000563588.6 [P15735-1] ENST00000565924.5 H3BTI9 H3BN16 ENST00000565897.5 |